Review: clinical opportunities provided by the nasal administration of peptides

Journal of Drug Targeting
A S Harris


Peptides are rapidly being developed as potential new therapeutic agents and the nasal route is being evaluated as a means of achieving systemic absorption. Current research in man is being directed at a number of polypeptides, including calcitonin, growth hormone releasing hormones (GHRH), insulin, gonadotropin hormone releasing hormones (GnRH) and vasopressin analogues. The underlying protective functions of the nose provide anatomical, temporal and enzymatic barriers to absorption of peptides. The nasal route is relatively unsuccessful when used for high molecular weight polypeptides. Penetration enhancers improve bioavailability but are poorly tolerated. Reproducibility of effect is highly variable, major contributing factors including the site of deposition and type of delivery system as well as changes in the mucous secretion and mucociliary clearance, compounded by the presence of allergy, hay fever and the common cold in treated subjects. The future potential for this route lies in development of effective and well tolerated formulations in highly accurate delivery systems for the chronic administration of peptides, enabling the replacement of impractical and invasive intravenous injections in patients on lifelong subst...Continue Reading


Oct 20, 1978·JAMA : the Journal of the American Medical Association·M E Kosman
Oct 1, 1976·British Journal of Clinical Pharmacology·F Y Aoki, J C Crowley
May 1, 1975·British Journal of Haematology·P M MannucciB Robertson
May 1, 1991·Journal of Pharmaceutical Sciences·S GizurarsonF Larsen
Aug 1, 1990·The Journal of Clinical Endocrinology and Metabolism·Y KhalfallahG Sassolas
Feb 1, 1990·American Journal of Obstetrics and Gynecology·D H Barlow
Mar 1, 1990·Journal of Pharmaceutical Sciences·D C CorboY W Chien
Aug 19, 1989·BMJ : British Medical Journal·K OvergaardM A Hansen
Feb 1, 1988·Antimicrobial Agents and Chemotherapy·F G HaydenJ K Albrecht
May 1, 1985·The Journal of Pharmacy and Pharmacology·J G HardyC G Wilson
Nov 1, 1987·Calcified Tissue International·H KuroseH Yabuuchi
Nov 1, 1987·Calcified Tissue International·T BuclinP Burckhardt
Jul 1, 1987·Diabetes Research and Clinical Practice·A G FraumanW J Louis
May 1, 1987·Journal of Pharmaceutical Sciences·J P LongeneckerE J Dubovi
Apr 1, 1988·Journal of Pharmaceutical Sciences·A S HarrisI M Nilsson
Nov 1, 1986·Acta Oto-laryngologica·M BendeU Pipkorn
Apr 25, 1985·The New England Journal of Medicine·R SalzmanJ Armstrong
Aug 1, 1985·Annals of Internal Medicine·D W Richardson, A G Robinson
Nov 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·G S GordonM C Carey
Feb 1, 1985·Journal of Endocrinological Investigation·W SchurrH P Merkle
May 11, 1985·British Medical Journal·A E PontiroliG Pozza
Apr 1, 1972·The Journal of Clinical Endocrinology and Metabolism·N FleischerM Calderon
Oct 1, 1974·European Journal of Pharmacology·J KynclJ Rudinger
Jan 1, 1973·Archives of Internal Medicine·D F Proctor, G Lundqvist

❮ Previous
Next ❯


Aug 30, 2000·Advanced Drug Delivery Reviews·Y H Lee, P J Sinko
Dec 10, 1998·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·C WadellO Camber
Aug 6, 2004·Journal of Pharmaceutical Sciences·Lisa TangBernd Meibohm
Apr 27, 2010·International Journal of Pharmaceutics·Zhengqi DongAkira Yamamoto
Feb 23, 2008·International Journal of Pharmaceutics·Bronislava R GedulinAndrew A Young
May 4, 2007·International Journal of Pharmaceutics·Henry R CostantinoSteven C Quay
Nov 9, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Takahiro MatsuyamaHiroyuki Yoshino
Oct 28, 2016·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Akiko TanakaAkira Yamamoto
Mar 21, 2000·Medicinal Research Reviews·A Leone-BayJ J Weidner
Jan 5, 2019·Biological & Pharmaceutical Bulletin·Shigehiro OmoriHideshi Natsume

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute viral rhinopharyngitis

Acute viral rhinopharyngitis, also known as "common cold", is an acute, self-limiting viral infection of the upper respiratory tract involving the nose, sinuses, pharynx and larynx. Discover the latest research on acute viral rhinopharyngitis here.